SCHEMBL4131870

SCHEMBL4131870

COc1cccc(C(=O)c2cc(Cl)ccc2-n2ccnc2)c1OC.COc1cccc(C(=O)c2cc(Cl)ccc2N)c1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.47
KMT2A Q03164 3/20 0.41
GAA P10253 1/20 0.41
HSD17B10 Q99714 1/20 0.41
RECQL P46063 1/20 0.40
CYP19A1 P11511 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
MEN1 O00255 1/20 0.40
DRD2 P14416 1/20 0.39
DRD1 P21728 1/20 0.39
AAK1 Q2M2I8 1/20 0.39
TUBB4A P04350 1/20 0.39
TUBB P07437 1/20 0.39
TUBA3C P0DPH7 1/20 0.39
TUBA1B P68363 1/20 0.39
TUBA4A P68366 1/20 0.39
TUBB4B P68371 1/20 0.39
TUBB3 Q13509 1/20 0.39
TUBB2A Q13885 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13775798 0.95 CYP19A1 (0.44) IDO1KMT2AGAAHSD17B10CYP19A1
SCHEMBL4125269 0.84 NR1I2 (0.39) IDO1KMT2ACYP19A1CYP11B1CYP11B2
SCHEMBL635552 0.83 RECQL (0.56) KMT2AGAAHSD17B10RECQL
SCHEMBL4122687 0.82 L3MBTL1 (0.44) KMT2ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL4124299 0.76 RECQL (0.50) KMT2AGAAHSD17B10RECQLMEN1
SCHEMBL11776837 0.76 RECQL (0.52) IDO1KMT2ARECQLMEN1DRD2
SCHEMBL4111889 0.75 TUBB4A (0.43) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL13775802 0.75 KMT2A (0.40) KMT2AGAAHSD17B10DRD2DRD1
SCHEMBL4117233 0.74 L3MBTL1 (0.41) KMT2AGAAMEN1TUBB4ATUBB
SCHEMBL13775799 0.74 ALDH1A1 (0.40) KMT2AGAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR IDO1 2943/4885KMT2A 1467/4885GAA 922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.